Home Page Image



Garrett Moraski

gmoraski@nd.edu

University of Notre Dame, B.S., 1997
Research Associate, Pfizer; Array Biopharma; Thios., 1997-2004
Research Associate, Marvin M. Miller Lab, 2004-current

Research

Design and synthesis of small-molecule anti-tuberculosis inhibitors

Publications and Presentations

"Streamlined Processes for the Synthesis of a Farnesyl ransferase Inhibitor Drug Candidate," Organic Process     Research & Development 2004, 8, 643-650.

"Antiangiogenic and Antitumor Activity of a Selective RDGFR Tyrosine Kinase Inhibitor," CP-673,451, Cancer Ressearch, 2005; 65: (3).  February 1, 2005.

“Probing the Structural Basis for Anti-Tuberculosis and Anti-Cancer Activity in Amamistatin and Mycobacteria Analogs,” NOS, 2005.

“Design, Synthesis, and Studies of Mycobacterial Siderophores with Selective Anti-TB Activity,” 2005 Keystone Meeting, Montreal, CA. 

“Design, Syntheses and Studies of Novel Anti-TB Agents Based on Mycobacterial Siderophores,” 2006 Gordon Conference, Ventura, CA. 

 

 

 

 

 
 
 

GrottoGrotto